Stockscreener 앱 받기
29.81
7.04%
1.96
시간 외 거래:
29.86
0.05
+0.17%
전일 마감가:
$27.85
열려 있는:
$28.68
하루 거래량:
11.57M
Relative Volume:
0.74
시가총액:
$6.51B
수익:
$1.24B
순이익/손실:
$101.26M
주가수익비율:
67.75
EPS:
0.44
순현금흐름:
$149.62M
1주 성능:
+13.74%
1개월 성능:
+13.78%
6개월 성능:
+53.50%
1년 성능:
+258.29%
1일 변동 폭
$28.01
$30.00
1주일 범위
$25.56
$30.00
52주 변동 폭
$8.44
$35.02
Hims Hers Health Inc Stock (HIMS) Company Profile
명칭
Hims Hers Health Inc
전화
415-851-0195
주소
2269 CHESTNUT ST, SAN FRANCISCO
HIMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
29.81 | 6.51B | 1.24B | 101.26M | 149.62M | 0.44 |
|
PG
Procter Gamble Co
|
161.72 | 379.90B | 83.91B | 14.32B | 15.85B | 5.80 |
|
UL
Unilever Plc Adr
|
56.91 | 140.75B | 64.93B | 7.15B | 0 | 2.832 |
|
CL
Colgate Palmolive Co
|
88.23 | 72.08B | 20.11B | 2.87B | 3.40B | 3.49 |
|
KMB
Kimberly Clark Corp
|
126.52 | 42.19B | 20.10B | 2.61B | 2.90B | 7.71 |
|
KVUE
Kenvue Inc
|
20.80 | 39.88B | 15.46B | 1.06B | 1.40B | 0.55 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-10 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-01-07 | 개시 | BTIG Research | Buy |
| 2024-12-17 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-08-22 | 개시 | Needham | Buy |
| 2024-08-09 | 다운그레이드 | Imperial Capital | Outperform → In-line |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-04-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-04-10 | 개시 | Canaccord Genuity | Buy |
| 2024-02-28 | 업그레이드 | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-07 | 개시 | Imperial Capital | In-line |
| 2023-07-28 | 개시 | TD Cowen | Outperform |
| 2023-04-11 | 개시 | Robert W. Baird | Neutral |
| 2023-02-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-08 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-07-15 | 개시 | SVB Leerink | Underperform |
| 2022-04-14 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-03-10 | 개시 | Deutsche Bank | Hold |
| 2021-12-02 | 개시 | Jefferies | Hold |
| 2021-11-11 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 개시 | BofA Securities | Neutral |
| 2021-05-20 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 개시 | Truist | Hold |
| 2021-03-09 | 개시 | Credit Suisse | Neutral |
| 2021-03-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 개시 | Citigroup | Neutral |
| 2021-02-12 | 개시 | Piper Sandler | Neutral |
| 2021-02-08 | 개시 | Tigress Financial | Buy |
모두보기
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Hims & Hers CEO Andrew Dudum sells $2.27 million in stock - Investing.com
Hims & Hers Health Unusual Options Activity - Benzinga
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Hims & Hers Health, Inc. (NYSE:HIMS) Shares Sold by Diversify Advisory Services LLC - MarketBeat
Hims & Hers Health Stock Climbs Following Q4 Earnings Beat, Revenue Beat, Guidance Above Estimates - MSN
Hims & Hers Health: A Stock to Trade or Own? - MSN
Hims & Hers: Ready To Outperform Further - Seeking Alpha
Hims & Hers Health: The Market Is Likely Wrong (NYSE:HIMS) - Seeking Alpha
Lake Street Private Wealth LLC Increases Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Oak Ridge Investments LLC Reduces Holdings in Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) Short Interest Update - MarketBeat
Hims & Hers Health (NYSE:HIMS) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Hims & Hers Health down 3% after BoA says Q4 revenue could be a miss - MSN
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today - sharewise
Noteworthy Friday Option Activity: UNH, HIMS, IGT - Nasdaq
BofA retains Hims & Hers stock rating amid pharma challenges - MSN
Hims & Hers Health Inc (HIMS) Shares Gap Down to $26.8776 on Jan 17 - GuruFocus.com
Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today - The Motley Fool
Top Growth Picks: 3 Low-Cost Stocks That Could Double in Value - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) Shares Bought by Carnegie Investment Counsel - MarketBeat
CHURCHILL MANAGEMENT Corp Purchases Shares of 18,392 Hims & Hers Health, Inc. (NYSE:HIMS) - MarketBeat
Hims & Hers Health (NYSE:HIMS) rises 8.3% this week, taking three-year gains to 474% - Simply Wall St
Is Hims & Hers Stock in Trouble? - MSN
(HIMS) Long Term Investment Analysis - Stock Traders Daily
Investors in Hims & Hers Health (NYSE:HIMS) have seen enviable returns of 440% over the past three years - Yahoo Finance
Hims & Hers CFO sells shares worth $283,083 By Investing.com - Investing.com Nigeria
Hims & Hers health chief commercial officer sells $174,724 in stock - Investing.com Nigeria
Insider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 7,259 Shares of Stock - MarketBeat
Hims & Hers Health, Inc. (NYSE:HIMS) CFO Sells $283,039.64 in Stock - MarketBeat
Hims & Hers Health, Inc. (HIMS) Laps the Stock Market: Here's Why - MSN
Hims & Hers health chief commercial officer sells $174,724 in stock By Investing.com - Investing.com South Africa
DOCS: 3 Telemedicine Stocks Making Healthcare More Accessible - StockNews.com
Hims & Hers in focus as Eli Lilly obesity drug sales disappoint - MSN
Hims & Hers stock up as Eli Lilly GLP-1 sales miss (LLY:NYSE) - Seeking Alpha
What’s Behind This Telehealth Stock’s 198% Rally? - substack.com
Hims & Hers Health down as Citi downgrades on GLP-1 revenue stream overvaluation - MSN
Hims & Hers Health Options Trading: A Deep Dive into Market Sentiment - Benzinga
GAMMA Investing LLC Buys 2,152 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) - Defense World
A 100x stock: Hims & Hers ($HIMS) - substack.com
Hims & Hers Health (NYSE:HIMS) Stock Rating Lowered by Citigroup - Defense World
Why Hims & Hers Health Stocks Are Dropping - TipRanks
Hims & Hers Stock Is Poised for a Major Surge in 2025 - MSN
Hims & Hers Health Inc (HIMS) Stock Price Down 4.82% on Jan 10 - GuruFocus.com
Hims & Hers Health (NYSE:HIMS) Shares Gap DownTime to Sell? - MarketBeat
Hims & Hers Stock Is Poised For A Major Surge In 2025 - Barchart
HIMS downgraded, agilon upgraded at Citi in 2025 Health Tech review - Seeking Alpha
Hims Hers Health Inc (HIMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
6.66%
0.18%
자본화:
|
볼륨(24시간):